Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D7GQR3
|
|||
| Drug Name |
CPK850
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Retinitis pigmentosa [ICD-11: 9B70; ICD-10: H35.5] | Phase 1/2 | [1] | |
| Company |
Novartis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03374657) A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.